Does Your Sperm Count Actually Matter? What the Research Shows on Concentration
Part 4 of the SwimScore Fertility Series: Sperm Concentration
Sperm count is the number most men think of first when they hear "fertility test." It's intuitive — more sperm means more chances, right? The reality is more nuanced than that, and more interesting. Concentration is genuinely important, but it interacts with other parameters in ways that make the raw number only part of the story. It also has the clearest and most consistent supplement evidence of any parameter in this series — with omega-3s and CoQ10 showing the strongest signals specifically here.
At SwimScore, we measure sperm concentration as a core part of every semen analysis, processed in a CLIA-certified lab against WHO 6th Edition clinical thresholds. Here is what the research actually shows about what your concentration number means, what drives it, and what you can do about it.
What Sperm Concentration Is and How It Differs From Sperm Count
These two terms are often used interchangeably but they measure different things. Sperm concentration is the number of sperm per milliliter of semen. Sperm count is the total number of sperm in the entire ejaculate — concentration multiplied by semen volume. A man can have high concentration and low count if his semen volume is very low, or low concentration and moderate count if his volume is high.
The WHO 6th Edition sets the reference threshold for sperm concentration at 16 million sperm per milliliter. Below this is classified as oligozoospermia. The total sperm count threshold sits at 39 million per ejaculate. Both matter clinically, but concentration is the more commonly referenced number in research and clinical practice.
It is also worth knowing that concentration is one of the parameters most affected by when a man last ejaculated, fever, illness, stress, and heat exposure in the weeks prior to testing. A single low result requires confirmation. The WHO recommends at least two tests separated by several weeks before drawing clinical conclusions.
Why Concentration Matters — And Where Its Importance Has Limits
A 2026 prospective cohort study following North American couples planning pregnancy found that low sperm concentration, defined as 16 million per milliliter or below, was associated with a fecundability ratio of 0.74 — meaning a roughly 26% reduction in the per-cycle probability of conception compared to men above the threshold. (Lovett et al., Andrology, 2026) A separate longitudinal study of over 6,000 subfertile men found that higher sperm concentration was consistently associated with earlier time to conception and higher overall conception rates, with the relationship extending well above the WHO reference range. (PMC, 2021)
That last finding is worth dwelling on. Higher concentration continues to be associated with better outcomes even in men above the 16 million threshold. More is genuinely better here, not just up to a reference range cutoff but beyond it. The relationship between concentration and conception probability is not binary — it's a gradient.
Where concentration shows its limits is as a standalone predictor. A man with low concentration but excellent progressive motility and low DNA fragmentation is in a meaningfully different situation from a man with low concentration alongside poor motility and elevated fragmentation. The Fertility and Sterility review makes this point clearly: individual semen parameters are generally poor predictors of natural conception success in isolation, but they become more informative when assessed together. (Fertility and Sterility, 2023) This is one reason we measure concentration alongside progressive motility, DNA fragmentation, morphology, and hormones rather than treating any single number as the definitive verdict.
The Broader Context: A Declining Number
Sperm concentration is also the parameter at the center of one of the most discussed trends in men's health. Multiple epidemiological studies and WHO manual updates have documented a meaningful decline in average sperm counts over recent decades — by some estimates close to 50% over the past 40 to 50 years in Western populations. (PMC, 2024) The causes are multi-factorial and contested: environmental toxins including plasticizers such as bisphenol A and phthalates, rising rates of obesity, sedentary lifestyles, heat exposure from modern working conditions, and chronic oxidative stress from diet and environmental pollution all appear to contribute.
This matters for how we think about what a "normal" concentration number actually means at a population level. The WHO reference range is derived from fertile men, not optimal men. Sitting above 16 million places you above the clinical threshold — but that threshold itself has been established against a population whose average sperm counts have been declining. Understanding your concentration in the context of where you want to be, not just where the floor is, is a more useful frame.
What Causes Low Sperm Concentration
Low concentration, clinically called oligozoospermia, has multiple possible causes that operate through different pathways.
Oxidative stress is the most common modifiable driver. High levels of reactive oxygen species in seminal plasma trigger apoptosis — programmed cell death — in developing sperm cells, reducing the number that complete maturation. Studies consistently show significantly higher oxidative stress markers in oligozoospermic men compared to men with normal concentration, with a strong negative correlation between reactive oxygen species levels and sperm concentration. (Clinical and Experimental Reproductive Medicine, 2025)
Hormonal dysfunction is the other major pathway. FSH drives sperm production in the testes. Testosterone, LH, and prolactin all play regulatory roles. When any of these are out of range — whether from lifestyle factors, underlying medical conditions, or external testosterone use — spermatogenesis is directly impaired and concentration drops. This is why we run a hormone panel alongside every semen analysis: low concentration with normal hormones points to a different cause than low concentration with suppressed FSH or testosterone.
Varicocele, the same dilated vein condition that affects DNA fragmentation and morphology, impairs concentration through chronic heat stress and oxidative damage in the testicular environment. In men with confirmed varicocele and oligozoospermia, surgical repair has meaningful evidence for improving concentration alongside other parameters.
Genetic factors including Y chromosome microdeletions and chromosomal abnormalities account for a proportion of severe oligozoospermia cases, particularly where concentration is very low or absent. These are not addressable through supplementation and require clinical genetic evaluation.
Lifestyle and environmental factors — obesity, smoking, chronic alcohol use, anabolic steroid use, occupational chemical exposure, heat exposure, and poor diet — all impair spermatogenesis through overlapping oxidative and hormonal mechanisms.
What the Research Shows on Supplements
This is where the concentration article differs from the previous three in this series. For progressive motility, L-carnitine had the most specific evidence. For DNA fragmentation, CoQ10 led. For morphology, the evidence was thin overall. For concentration, the supplement picture is both broader and more consistent — with omega-3s and CoQ10 showing the strongest signals, and zinc and folate contributing meaningful evidence alongside them.
Omega-3 fatty acids have their strongest evidence in the entire supplement literature specifically for sperm concentration. The Salas-Huetos 2018 meta-analysis of randomized clinical trials found that omega-3 supplementation increased sperm concentration by a mean of 10.98 million sperm per milliliter — the largest concentration improvement of any supplement tested. Total sperm count also increased by 18.70 million per ejaculate. (Salas-Huetos et al., Advances in Nutrition, 2018) The mechanism is structural: DHA, the primary omega-3 in sperm cell membranes, is essential for the normal development and survival of sperm cells during spermatogenesis. Deficiency in DHA is associated with impaired sperm production and higher rates of developmental failure.
A 2024 controlled trial in men with low sperm concentration found that 2 grams of omega-3 fatty acids daily for 12 weeks increased sperm concentration from approximately 11 to 34 million per milliliter — and 76.7% of men in the trial reached normal concentration levels. (Hosseini et al., Andrology, 2024) That is a clinically meaningful shift in the right direction, in a well-designed trial, in the population it most matters for.
We noted in the progressive motility article that we were skeptical of omega-3s for PR specifically — because the rigorous Henriksen 2025 analysis found no significant motility improvement when restricted to high-quality placebo-controlled trials. For concentration, the picture is different. The evidence is more consistent and the effect sizes are larger. This is where omega-3s belong in the supplement conversation.
CoQ10 has strong concentration evidence alongside its motility benefits. A 2025 meta-analysis of nine randomized controlled trials in 781 men found that CoQ10 supplementation improved sperm concentration by a mean difference of 10.22 million per milliliter — a statistically significant and clinically meaningful improvement. (World Journal of Men's Health, 2025) The Salas-Huetos 2018 meta-analysis similarly found a mean concentration increase of 5.93 million per milliliter from CoQ10. (Salas-Huetos et al., Advances in Nutrition, 2018) The mechanism for concentration is distinct from its motility mechanism: beyond energy production, CoQ10's antioxidant function in seminal plasma reduces the reactive oxygen species-driven apoptosis that kills developing sperm before they complete maturation.
Zinc and folate showed statistically significant concentration improvements in the Henriksen 2025 analysis — one of only three supplement categories to do so in that rigorous review. (Henriksen et al., Nutrients, 2025) Zinc plays a direct role in spermatogenesis enzymes and testosterone synthesis. Low zinc is associated with suppressed testosterone and impaired sperm production. Folate is involved in DNA synthesis, which is fundamental to the cell division that produces new sperm. Their combination appears more effective than either alone in the trials studied. Notably, the Henriksen subgroup analysis specifically on oligozoospermic men confirmed concentration improvements — making this the one parameter where even the most rigorous recent review found supplement benefits in the specific population most affected.
Selenium improved sperm concentration in the Salas-Huetos meta-analysis with a mean increase of 3.91 million per milliliter. (Salas-Huetos et al., Advances in Nutrition, 2018) The Henriksen analysis found a non-significant trend. Selenium's concentration evidence is real but less consistent than for omega-3s and CoQ10. It is best considered as a supporting compound in a broader stack rather than the primary intervention for concentration specifically.
What the Research Doesn't Show
Consistent with our approach throughout this series: the Henriksen 2025 review found no effect of any supplement on pregnancy or live birth rates, even where concentration improved. We hold this finding the same way we've held it across the series — pregnancy is a multi-variable outcome and concentration is one input into it. Improving concentration improves the number of sperm available every cycle. Whether that improvement shows up in pregnancy statistics across a mixed population of couples is a different and harder question to answer cleanly.
What we will add specifically for concentration: oligozoospermia can have structural or genetic causes that supplements cannot address. If concentration is very low — below 5 million per milliliter — the probability of a supplement-driven improvement is lower and the importance of clinical investigation is higher. Hormone testing, genetic screening, and urological evaluation become more relevant the more severe the oligozoospermia is.
How to Think About This Practically
Confirm the number before acting on it. Concentration is more variable between tests than any other parameter. A single result below 16 million should be repeated before drawing conclusions or beginning a supplement protocol. Illness, stress, heat exposure in the prior six to eight weeks, and abstinence period all affect the result meaningfully.
Check your hormones alongside your concentration. Low concentration with suppressed FSH or testosterone points toward a hormonal problem that supplements cannot fix. Low concentration with normal hormones points toward an oxidative stress or nutritional mechanism that supplementation can address. The distinction matters.
For oligozoospermia driven by oxidative stress or nutritional factors, omega-3s and CoQ10 have the strongest concentration-specific evidence. Zinc and folate add meaningful support, particularly given their specific confirmation in the oligozoospermia subgroup of the most rigorous recent review.
Don't ignore the lifestyle drivers. Obesity, smoking, chronic alcohol use, anabolic steroid use, and heat exposure are all directly associated with reduced sperm production. These are not soft suggestions — each has documented mechanisms for impairing spermatogenesis. Addressing them moves the needle in ways that supplements cannot fully compensate for.
Think beyond the 16 million threshold. The research shows that higher concentration is associated with better outcomes even above the reference range. If you're at 20 million, there is still a reasonable case for optimizing further — particularly if you're actively trying to conceive and your other parameters are borderline.
Measure before. Measure after. At minimum 12 weeks between tests — one full spermatogenesis cycle. Without a baseline, you cannot know what changed. Without a follow-up, you cannot know if the intervention worked.
Our Take
Sperm concentration is a genuinely important parameter with a clear and consistent relationship to natural conception probability. It is also the parameter with the broadest and most consistent supplement evidence in this series. Omega-3s and CoQ10 have the strongest and most specific concentration data. Zinc and folate add meaningful support and are the only supplement category confirmed to improve concentration in oligozoospermic men specifically in the most rigorous recent review.
We know supplements improve concentration. We know higher concentration improves per-cycle conception odds. Whether supplement-driven concentration increases translate to measurably better pregnancy rates hasn't been clinically proven. The biological logic is sound. Optimizing what you can control is rational.
Know your number. Understand what's driving it. Target the right intervention for the right cause. Measure again.
This is Part 4 of the SwimScore Fertility Series. Next up: Putting It All Together — how the parameters interact, what TMSC means for treatment decisions, and how to read your full SwimScore report.
SwimScore uses CLIA-certified labs for all semen analysis and hormone testing, assessed against WHO 6th Edition clinical thresholds.
See part 1 of our series on progressive motility, part 2 on DNA fragmentation, and part 3 on morphology
